It is unknown whether the histologic subtypes of basal cell carcinoma (BCC) arise from a common progenitor cell or whether other factors play a role in their development.
Objective:
To investigate the relationship between the different BCC histopathologic subtypes and anatomical distribution of BCCs in a Canadian dermatology practice.
Methods:
The charts of all patients diagnosed with BCC between 1993 and 2005 from a single private dermatology practice in Vancouver, Canada, were reviewed. Descriptive data analysis was undertaken to look at the distribution of histologic subtypes based on age, gender, and anatomical location.
Results:
Nodular BCCs accounted for 58% of all tumors. Sixty-six percent of these were situated on the head/neck (odds ratio [OR] = 3.0, 95% confidence interval [CI] = 2.1-4.3, P < .0001). Infiltrative (OR = 2.4, 95% CI = 1.5-4.1, P = .0003) and superficial BCCs were more common in women (OR = 3.7, 95% CI = 2.5-5.7, P < .0001), affected the trunk (OR = 3.2, 95% CI = 2.1-4.9, P < .0001), and appeared in younger individuals (OR = 1.8, 95% CI = 1.2-2.7, P = .004).
Conclusion:
Our results show a preference of distinct BCC subtypes for certain anatomical locations.
SextonMJonesDBMaloneyME. Histologic pattern analysis of basal cell carcinoma: study of a series of 1039 consecutive neoplasms. J Am Acad Dermatol. 1990;23:1118-1126.
4.
RohSParkJSongKNamKYunSKimH. Clinical and histopathological characteristics of extra-facial basal cell carcinoma: analysis of 35 patients at the Chonbuk National University Hospital in Korea. Australasian J Dermatol. 2014;55(4):e65-e68.
5.
HeckmannMZogelmeierFKonzB. Frequency of facial basal cell carcinoma does not correlate with site-specific UV exposure. Arch Dermatol. 2002;138:1494-1497.
6.
LeeYJChoiHJYunSKKimHUIhmCW. A case of basal cell carcinoma of the penis. Korean J Dermatol. 2004;42:350-352.
7.
ZargaranMMoghimbeigiAMonsefATeimourianHShojaeiS. A clinicopathological survey of basal cell carcinoma in an Iranian population. J Dent Shiraz Univ Med Sci Dec. 2013;14(4):170-177.
8.
FriedmanGDTekawaIS. Association of basal cell skin cancers with other cancers (United States). Cancer Causes Control. 2000;11:891-897.
9.
LearWDahlkeEMurrayCA. Basal cell carcinoma: review of epidemiology, pathogenesis, and associated risk factors. J Cutan Med Surg. 2007;11(1):19-30.
10.
CoronaRDogliottiED’ErricoMRisk factors for basal cell carcinoma in a Mediterranean population: role of recreational sun exposure early in life. Arch Dermatol. 2001;137(9):1162-1168.
11.
BastiaensMTHoefnagelJJBruijnJADifferences in age, site distribution, and sex between nodular and superficial basal cell carcinoma indicate different types of tumors. J Invest Dermatol. 1998;110(6):880-884.
12.
McCormackCJKellyJWDorevitchAP. Differences in age and body site distribution of the histological subtypes of basal cell carcinoma: a possible indicator of differing causes. Arch Dermatol. 1997;133(5):593-596.
13.
RoweDGallagherRPWarshawskiLCarruthersA. Females vastly outnumber males in basal cell carcinoma of the upper lip. J Dermatol Surg Oncol. 1994;20(11):754-756.
14.
HakverdiSBalciDDDogramaciCAToprakSYaldizM. Retrospective analysis of basal cell carcinoma. Indian J Dermatol Venereol Leprol. 2011;77(2):251.
15.
ShrivastavaRSinghKKShriveastavaM. Soft tissue metastasis in basal cell carcinoma. Indian J Dermatol. 2007;52(4):206-208.
16.
KikuchiAShimizuHNishikawaT. Clinical and histological characteristics of basal cell carcinoma in Japanese patients. Arch Dermatol. 1996;132:320-324.
17.
SaldanhaGFletcherASlaterDN. Basal cell carcinoma: a dermatopathological and molecular biological update. Br J Dermatol. 2003;148(2):195-202.
18.
VantuchovaYCurikR. Histological types of basal cell carcinoma. Scripta Medica (Brno). 2006;79:261-270.
19.
GhanadanAAbbasiARabetMAbdollahiPAbbasiM. Characteristics of mixed type basal cell carcinoma in comparison to other Bcc subtypes. Indian J Dermatol. 2014;59(1):56-59.
20.
Ghafouri-FardSAbbasiAMoslehiHElevated expression levels of testis-specific genes tex101 and spata19 in basal cell carcinoma and their correlation with clinical and pathological features. Br J Dermatol. 2010;162(4):772-779.
21.
TilliCMVan SteenselMAKrekelsGANeumannHARamaekersFC. Molecular aetiology and pathogenesis of basal cell carcinoma. Br J Dermatol. 2005;152(6):1108-1124.
ScrivenerYGrosshansECribierB. Variations of basal cell carcinomas according to gender, age, location, and histopathologic subtype. Br J Dermatol. 2002;147(1):41-47.
24.
BettiRRadaelliGMussinoFMenniSCrostiC. Anatomic location and histopathologic subtype of basal cell carcinomas in adults younger than 40 or 90 and older: any difference?Dermatol Surg. 2009;35(2):201-206.
25.
BettiRRadaelliGBombonatoCCrostiCCerriAMenniS. Anatomic location of basal cell carcinomas may favor certain histologic subtypes. J Cutan Med Surg. 2010;14(6):298-302.
26.
AritsASchlangenMNelemansPKelleners-SmeetsN. Trends in the incidence of basal cell carcinoma by histopathologic subtype. J Eur Acad Dermatol Venereol. 2010;25(5):565-569.
27.
BettiRMenniSRadaelliGBombonatoCCrostiC. Micronodular basal cell carcinoma: a distinct subtype? Relationship with nodular and infiltrative basal cell carcinomas. J Dermatol. 2010;37(7):611-616.
28.
ChenCCChenCL. Clinical and histopathologic findings of superficial basal cell carcinoma: a comparison with other basal cell carcinoma subtypes. J Chin Med Assoc. 2006;69(8):364-371.
29.
GhanadanAAbdollahiPRabetMDifferent anatomical distribution of basal cell carcinoma subtypes in Iranian population: association between site and subtype. Ann Dermatol. 2014;26(5):559-563.
30.
SchinstineMGoldmanGD. Risk of synchronous and metachronous second nonmelanoma skin cancer when referred for Mohs micrographic surgery. J Am Acad Dermatol. 2001;44(3):497-499.
31.
CantwellMMMurrayLJCatneyDSecond primary cancers in patients with skin cancer: a population-based study in Northern Ireland. Br J Cancer. 2009;100(1):174-177.
32.
MaitraSKGalloHRowland-PayneCRobinsonDMollerH. Second primary cancers in patients with squamous cell carcinoma of the skin. Br J Cancer. 2005;92(3):570-571.
33.
WassbergCThornMYuenJRingborgUHakulinenT. Second primary cancers in patients with squamous cell carcinoma of the skin: a population-based study in Sweden. Int J Cancer. 1999;80(4):511-515.
34.
HutchinMEKariapperMSTGrachtchoukMSustained hedgehog signaling is required for basal cell carcinoma proliferation and survival: conditional skin tumorigenesis recapitulates the hair growth cycle. Genes Dev. 2005; 19(2):214-223.
35.
HoffDDLoRussoPMRudinCMInhibition of the hedgehog pathway in advanced basal-cell carcinoma. N Engl J Med. 2009;361(12):1164-1172.
36.
SaladiRNNektalovaTFoxJL. Induction of skin carcinogenicity by alcohol and ultraviolet light. Clin Exp Dermatol. 2009;35(1):7-11.
37.
TehMTWongSTNeillGWGhaliLRPhilpottMPQuinnAG. FOXM1 is a downstream target of Gli1 in basal cell carcinomas. Cancer Res. 2002;62(16):4773-4780.
38.
YangSHAndlTGrachtchoukVPathological responses to oncogenic hedgehog signaling in skin are dependent on canonical Wnt/b-catenin signaling. Nat Genet. 2008;40(9):1130-1135.
BarrettTLSmithKJHodgeJJImmunohistochemical nuclear staining for p53, PCNA, and Ki-67 in different histologic variants of basal cell carcinoma. J Am Acad Dermatol. 1997;37(3 pt 1):430-437.
41.
D’ErricoMCalcagnileASCoronaRP53 mutations and chromosome instability in basal cell carcinomas developed at an early or late age. Cancer Res. 1997;57(4):747-752.
42.
LearJTSmithABowersBTruncal tumor site is associated with high risk of multiple cutaneous basal cell carcinoma and is influenced by glutathione S-transferase, GSTT1 and cytochrome P450, CYP1A1 genotypes and their interactions. J Invest Dermatol. 1997;108(4):519-522.
43.
BergDOtleyCC. Skin cancer in organ transplant recipients: epidemiology, pathogenesis, and management. J Am Acad Dermatol. 2002;47(1):1-17.
44.
TessariGNaldiLBoschieroLIncidence and clinical predictors of a subsequent NMSC in solid organ transplant recipients with a first nonmelanoma skin cancer: a multicenter cohort study. Arch Dermatol. 2010;146(3):294-299.
45.
SitumMBuljanMBulatVLugović MihićLBolancaZSimićD. The role of UV radiation in the development of basal cell carcinoma. Coll Antropol. 2008;32(suppl 2):167-170.
46.
SchmittJDiepgenTBauerA. Occupational exposure to non-artificial UV-light and non-melanocytic skin cancer: a systematic review concerning a new occupational disease. J Dtsch Dermatol Ges. 2010;8(4):250-264.
47.
DownsNParisiA. Measurements of the anatomical distribution of erythemal ultraviolet: a study comparing exposure distribution to the site incidence of solar keratoses, basal cell carcinoma, and squamous cell carcinoma. Photochem Photobiol Sci. 2009;8(8):1195-1201.
48.
LeiterUGarbeC. Epidemiology of melanoma and nonmelanoma skin cancer: the role of sunlight. Adv Exp Med Biol. 2008;624:89-103.
49.
LesiakASlowik-RylskaMRogowski-TylmanMSysa-JedrzejowskaANorvalMNarbuttJ. Risk factors in central Poland for the development of superficial and nodular basal cell carcinomas. Arch Med Sci. 2010;6:270-275.
50.
BoydASShyrYKingLE. Basal cell carcinoma in young women: an evaluation of the association of tanning bed use and smoking. J Am Acad Dermatol. 2002;46(5):706-709.
51.
BarianiRLNahasFXBarbosaMVFarahABFerreiraLM. Basal cell carcinoma: an updated epidemiological and therapeutically profile of an urban population. Acta Cirurgica Brasileria. 2006;21(2):66-73.
52.
FaurschouAWulfHC. Ecological analysis of the relation between sunbeds and skin cancer. Photodermatol Photoimmunol Photomed. 2007;23(4):120-125.
53.
FerucciLMCartmelBMolindaroAMLeffellDJBaleAEMayneST. Indoor tanning and risk of early-onset basal cell carcinoma. J Am Acad Dermatol. 2011;67(4):552-562.
54.
ZhangMQureshiAAGellerACFrazierLHunterDJHanJ. Use of tanning beds and incidence of skin cancer. J Clin Oncol. 2012;30(14):1588-1593.
55.
KaragasMRStannardVAMottLASlatteryMJSpencerSKWeinstockMA. Use of tanning devices and risk of basal cell and squamous cell skin cancers. J Natl Cancer Inst. 2002;94(3):224-226.
56.
BajdikCDGallagherRPAstrakianakisGHillGBFinchamSMcLeanDI. Non-solar ultraviolet radiation and the risk of basal and squamous cell skin cancer. Br J Cancer. 1996;73(12):1612-1614.
57.
WaltherUKronMSanderSRisk and protective factors for sporadic basal cell carcinoma: results of a two-centre case-control study in southern Germany. Clinical actinic elastosis may be a protective factor. Br J Dermatol. 2004;151(1):170-178.
58.
TewariASarkanyRPYoungAR. UVA1 induces cyclobutane pyrimidine dimmers but not 6-4 photoproducts in human skin in vivo. J Invest Dermatol. 2012;132:394-400.
59.
DakuboGDJakupciakJPBirch-MachinMAParrRL. Clinical implications and utility of field cancerization. Cancer Cell Int. 2007;7:2.
60.
HoyWE. Nonmelanoma skin carcinoma in Albuquerque, New Mexico: experience of a major health care provider. Cancer. 1996;77(12):2489-2495.
61.
MarghoobAASladeJSalopekTGKopfAWBartRSRigelDS. Basal cell and squamous cell carcinomas are important risk factors for cutaneous malignant melanoma: screening implications. Cancer. 1995;75(2 suppl):707-714.
62.
MarcilISternRS. Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: a critical review of the literature and meta-analysis. Arch Dermatol. 2000;136(12):1524-1530.
63.
TroyanovaPDanonSIvanovaT. Nonmelanoma skin cancers and risk of subsequent malignancies: a cancer registry-based study in Bulgaria. Neoplasma. 2002;49(2):81-85.
64.
FrischMHjalgrimHOlsenJHMelbyeM. Risk for subsequent cancer after diagnosis of basal-cell carcinoma: a population-based, epidemiologic study. Ann Intern Med. 1996;125(10):815-821.
KaragasMRGreenbergERMottLABaronJAErnsterVL. Occurrence of other cancers among patients with prior basal cell and squamous cell skin cancer. Cancer Epidemiol Biomarkers Prev. 1998;7(2):157-161.
67.
ReesJRZensMSGuiJCelayaMORiddleBLKaragasMR. Non melanoma skin cancer and subsequent cancer risk. PloS One. 2014;9(6):e99674.
68.
McCuskerMBasset-SeguinNDummerRMetastatic basal cell carcinoma: prognosis dependent on anatomic site and spread of disease. Eur J Cancer. 2014;50(4):774-783.
69.
CirroneFHarrisCS. Vismodegib and the hedgehog pathway: a new treatment for basal cell carcinoma. Clin Ther. 2012;34(10):2039-2050.
70.
McLeanDIPhillisNZhouYGallagherRLeeTK. 40-year trends in skin cancer in British Columbia, Canada, 1973-2003. J Cutan Med Surg. 2012;16(2):83-91.
